▶ 調査レポート

メトホルミン薬の世界市場 2020年

• 英文タイトル:Global Metformin Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。メトホルミン薬の世界市場 2020年 / Global Metformin Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / GIR201105240資料のイメージです。• レポートコード:GIR201105240
• 出版社/出版日:GlobalInfoResearch / 2020年10月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、メトホルミン薬の世界市場を調査対象にし、メトホルミン薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(50錠、100錠、その他)、用途別分析(病院、ドラッグストア)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:Novartis、Atlas Pharmaceuticals、Mallinckrodt、Apotex、Dr. Reddy’s Laboratories、Mylan、Torrent Pharmaceuticals、Alkem、Teva Pharmaceuticals、Sun Pharmaceutical Industries、Bristol-Myers Squibb
・メーカー別販売量、売上、市場シェア
・メトホルミン薬の地域別市場分析
・メトホルミン薬の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・メトホルミン薬のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・メトホルミン薬のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・メトホルミン薬の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・メトホルミン薬の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・メトホルミン薬の種類別市場規模2015-2020:50錠、100錠、その他
・メトホルミン薬の用途別市場規模2015-2020:病院、ドラッグストア
・メトホルミン薬の世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論

Market Overview
The global Metformin Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Metformin Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Metformin Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Metformin Drugs market has been segmented into
50 Tablets
100 Tablets
Other

By Application, Metformin Drugs has been segmented into:
Hospital
Drugs Stores

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Metformin Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Metformin Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Metformin Drugs market.

The report offers in-depth assessment of the growth and other aspects of the Metformin Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Metformin Drugs Market Share Analysis
Metformin Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Metformin Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Metformin Drugs sales, revenue and market share for each player covered in this report.

The major players covered in Metformin Drugs are:
Novartis
Atlas Pharmaceuticals
Mallinckrodt
Apotex
Dr. Reddy’s Laboratories
Mylan
Torrent Pharmaceuticals
Alkem
Teva Pharmaceuticals
Sun Pharmaceutical Industries
Bristol-Myers Squibb

Among other players domestic and global, Metformin Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Metformin Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Metformin Drugs, with price, sales, revenue and global market share of Metformin Drugs in 2018 and 2019.
Chapter 3, the Metformin Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Metformin Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Metformin Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Metformin Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Metformin Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Metformin Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 50 Tablets
1.2.3 100 Tablets
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Metformin Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drugs Stores
1.4 Overview of Global Metformin Drugs Market
1.4.1 Global Metformin Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Atlas Pharmaceuticals
2.2.1 Atlas Pharmaceuticals Details
2.2.2 Atlas Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Atlas Pharmaceuticals SWOT Analysis
2.2.4 Atlas Pharmaceuticals Product and Services
2.2.5 Atlas Pharmaceuticals Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Mallinckrodt SWOT Analysis
2.3.4 Mallinckrodt Product and Services
2.3.5 Mallinckrodt Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Apotex
2.4.1 Apotex Details
2.4.2 Apotex Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Apotex SWOT Analysis
2.4.4 Apotex Product and Services
2.4.5 Apotex Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Dr. Reddy’s Laboratories
2.5.1 Dr. Reddy’s Laboratories Details
2.5.2 Dr. Reddy’s Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Dr. Reddy’s Laboratories SWOT Analysis
2.5.4 Dr. Reddy’s Laboratories Product and Services
2.5.5 Dr. Reddy’s Laboratories Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Mylan SWOT Analysis
2.6.4 Mylan Product and Services
2.6.5 Mylan Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Torrent Pharmaceuticals
2.7.1 Torrent Pharmaceuticals Details
2.7.2 Torrent Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Torrent Pharmaceuticals SWOT Analysis
2.7.4 Torrent Pharmaceuticals Product and Services
2.7.5 Torrent Pharmaceuticals Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Alkem
2.8.1 Alkem Details
2.8.2 Alkem Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Alkem SWOT Analysis
2.8.4 Alkem Product and Services
2.8.5 Alkem Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Teva Pharmaceuticals
2.9.1 Teva Pharmaceuticals Details
2.9.2 Teva Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Teva Pharmaceuticals SWOT Analysis
2.9.4 Teva Pharmaceuticals Product and Services
2.9.5 Teva Pharmaceuticals Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sun Pharmaceutical Industries
2.10.1 Sun Pharmaceutical Industries Details
2.10.2 Sun Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sun Pharmaceutical Industries SWOT Analysis
2.10.4 Sun Pharmaceutical Industries Product and Services
2.10.5 Sun Pharmaceutical Industries Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Bristol-Myers Squibb
2.11.1 Bristol-Myers Squibb Details
2.11.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Bristol-Myers Squibb SWOT Analysis
2.11.4 Bristol-Myers Squibb Product and Services
2.11.5 Bristol-Myers Squibb Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Metformin Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Metformin Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Metformin Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Metformin Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Metformin Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Metformin Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Metformin Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Metformin Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Metformin Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Metformin Drugs Sales and Growth Rate (2015-2020)
4.5 South America Metformin Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Metformin Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Metformin Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Metformin Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Metformin Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Metformin Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Metformin Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Metformin Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Metformin Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Metformin Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Metformin Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Metformin Drugs Sales and Growth Rate (2015-2020)
6.3 UK Metformin Drugs Sales and Growth Rate (2015-2020)
6.4 France Metformin Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Metformin Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Metformin Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Metformin Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Metformin Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Metformin Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Metformin Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Metformin Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Metformin Drugs Sales and Growth Rate (2015-2020)
7.5 India Metformin Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Metformin Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Metformin Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Metformin Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Metformin Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Metformin Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Metformin Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Metformin Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Metformin Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Metformin Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Metformin Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Metformin Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Metformin Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Metformin Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Metformin Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Metformin Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Metformin Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Metformin Drugs Price by Type (2015-2020)
11 Global Metformin Drugs Market Segment by Application
11.1 Global Metformin Drugs Sales Market Share by Application (2015-2020)
11.2 Global Metformin Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Metformin Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Metformin Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Metformin Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Metformin Drugs Market Forecast (2021-2025)
12.2.2 Europe Metformin Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Metformin Drugs Market Forecast (2021-2025)
12.2.4 South America Metformin Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Metformin Drugs Market Forecast (2021-2025)
12.3 Metformin Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Metformin Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Metformin Drugs Market Share Forecast by Type (2021-2025)
12.4 Metformin Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Metformin Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Metformin Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Metformin Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Metformin Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Metformin Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Metformin Drugs Major Business
Table 9. Novartis Metformin Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Novartis SWOT Analysis
Table 11. Novartis Metformin Drugs Product and Services
Table 12. Novartis Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Atlas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Atlas Pharmaceuticals Metformin Drugs Major Business
Table 15. Atlas Pharmaceuticals Metformin Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Atlas Pharmaceuticals SWOT Analysis
Table 17. Atlas Pharmaceuticals Metformin Drugs Product and Services
Table 18. Atlas Pharmaceuticals Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 20. Mallinckrodt Metformin Drugs Major Business
Table 21. Mallinckrodt Metformin Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Mallinckrodt SWOT Analysis
Table 23. Mallinckrodt Metformin Drugs Product and Services
Table 24. Mallinckrodt Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Apotex Basic Information, Manufacturing Base and Competitors
Table 26. Apotex Metformin Drugs Major Business
Table 27. Apotex Metformin Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Apotex SWOT Analysis
Table 29. Apotex Metformin Drugs Product and Services
Table 30. Apotex Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Dr. Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 32. Dr. Reddy’s Laboratories Metformin Drugs Major Business
Table 33. Dr. Reddy’s Laboratories Metformin Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Dr. Reddy’s Laboratories SWOT Analysis
Table 35. Dr. Reddy’s Laboratories Metformin Drugs Product and Services
Table 36. Dr. Reddy’s Laboratories Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Mylan Basic Information, Manufacturing Base and Competitors
Table 38. Mylan Metformin Drugs Major Business
Table 39. Mylan Metformin Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Mylan SWOT Analysis
Table 41. Mylan Metformin Drugs Product and Services
Table 42. Mylan Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Torrent Pharmaceuticals Metformin Drugs Major Business
Table 45. Torrent Pharmaceuticals Metformin Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Torrent Pharmaceuticals SWOT Analysis
Table 47. Torrent Pharmaceuticals Metformin Drugs Product and Services
Table 48. Torrent Pharmaceuticals Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Alkem Basic Information, Manufacturing Base and Competitors
Table 50. Alkem Metformin Drugs Major Business
Table 51. Alkem Metformin Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Alkem SWOT Analysis
Table 53. Alkem Metformin Drugs Product and Services
Table 54. Alkem Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Teva Pharmaceuticals Metformin Drugs Major Business
Table 57. Teva Pharmaceuticals Metformin Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Teva Pharmaceuticals SWOT Analysis
Table 59. Teva Pharmaceuticals Metformin Drugs Product and Services
Table 60. Teva Pharmaceuticals Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 62. Sun Pharmaceutical Industries Metformin Drugs Major Business
Table 63. Sun Pharmaceutical Industries Metformin Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Sun Pharmaceutical Industries SWOT Analysis
Table 65. Sun Pharmaceutical Industries Metformin Drugs Product and Services
Table 66. Sun Pharmaceutical Industries Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 68. Bristol-Myers Squibb Metformin Drugs Major Business
Table 69. Bristol-Myers Squibb Metformin Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Bristol-Myers Squibb SWOT Analysis
Table 71. Bristol-Myers Squibb Metformin Drugs Product and Services
Table 72. Bristol-Myers Squibb Metformin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Metformin Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global Metformin Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Metformin Drugs Sales by Regions (2015-2020) (K Units)
Table 76. Global Metformin Drugs Sales Market Share by Regions (2015-2020)
Table 77. Global Metformin Drugs Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Metformin Drugs Sales by Countries (2015-2020) (K Units)
Table 79. North America Metformin Drugs Sales Market Share by Countries (2015-2020)
Table 80. North America Metformin Drugs Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Metformin Drugs Revenue Market Share by Countries (2015-2020)
Table 82. Europe Metformin Drugs Sales by Countries (2015-2020) (K Units)
Table 83. Europe Metformin Drugs Sales Market Share by Countries (2015-2020)
Table 84. Europe Metformin Drugs Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Metformin Drugs Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific Metformin Drugs Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Metformin Drugs Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Metformin Drugs Sales by Countries (2015-2020) (K Units)
Table 89. South America Metformin Drugs Sales Market Share by Countries (2015-2020)
Table 90. South America Metformin Drugs Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Metformin Drugs Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Metformin Drugs Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa Metformin Drugs Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Metformin Drugs Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Metformin Drugs Revenue Market Share by Countries (2015-2020)
Table 96. Global Metformin Drugs Sales by Type (2015-2020) (K Units)
Table 97. Global Metformin Drugs Sales Share by Type (2015-2020)
Table 98. Global Metformin Drugs Revenue by Type (2015-2020) (USD Million)
Table 99. Global Metformin Drugs Revenue Share by Type (2015-2020)
Table 100. Global Metformin Drugs Sales by Application (2015-2020) (K Units)
Table 101. Global Metformin Drugs Sales Share by Application (2015-2020)
Table 102. Global Metformin Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global Metformin Drugs Market Share Forecast by Regions (2021-2025)
Table 104. Global Metformin Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global Metformin Drugs Market Share Forecast by Type (2021-2025)
Table 106. Global Metformin Drugs Sales Forecast by Application (2021-2025)
Table 107. Global Metformin Drugs Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Metformin Drugs Picture
Figure 2. Global Sales Market Share of Metformin Drugs by Type in 2019
Figure 3. 50 Tablets Picture
Figure 4. 100 Tablets Picture
Figure 5. Other Picture
Figure 6. Metformin Drugs Sales Market Share by Application in 2018
Figure 7. Hospital Picture
Figure 8. Drugs Stores Picture
Figure 9. Global Metformin Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Metformin Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Metformin Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Metformin Drugs Sales Market Share by Manufacturer in 2019
Figure 30. Global Metformin Drugs Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Metformin Drugs Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Metformin Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Metformin Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Metformin Drugs Revenue Market Share by Regions (2015-2020)
Figure 37. Global Metformin Drugs Revenue Market Share by Regions in 2018
Figure 38. North America Metformin Drugs Sales and Growth Rate (2015-2020)
Figure 39. Europe Metformin Drugs Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Metformin Drugs Sales and Growth Rate (2015-2020)
Figure 41. South America Metformin Drugs Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Metformin Drugs Sales and Growth Rate (2015-2020)
Figure 43. North America Metformin Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Metformin Drugs Sales Market Share by Countries (2015-2020)
Figure 45. North America Metformin Drugs Sales Market Share by Countries in 2018
Figure 46. North America Metformin Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Metformin Drugs Revenue Market Share by Countries in 2018
Figure 48. United States Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Metformin Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Metformin Drugs Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Metformin Drugs Revenue Market Share by Countries in 2019
Figure 54. Germany Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Metformin Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Metformin Drugs Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Metformin Drugs Revenue Market Share by Regions 2019
Figure 62. China Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Metformin Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Metformin Drugs Sales Market Share by Countries in 2019
Figure 69. South America Metformin Drugs Revenue Market Share by Countries in 2019
Figure 70. Brazil Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Metformin Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Metformin Drugs Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Metformin Drugs Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Metformin Drugs Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Metformin Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Metformin Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Metformin Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Metformin Drugs Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Metformin Drugs Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Metformin Drugs Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Metformin Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Metformin Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel